We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-2.05%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$551K
AUM Growth
+$45.7K
Cap. Flow
+$48.3K
Cap. Flow %
8.77%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Avg Time Held
1 quarter
Top 10 Avg Time Held
1 quarter
Top 20 Avg Time Held
1 quarter

Top Buys

Rank Stock Value
1
KRSA
Korsana Biosciences, Inc. Common Stock
KRSA
+$48.3K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KRSA
1
Korsana Biosciences, Inc. Common Stock
KRSA
$1.54B
$551K 100%
23,490
+2,388
+11% +$48.3K
2023 Q3
1 quarter

Similar funds

Tyndall Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Tyndall Capital Partners held 1 position worth $551K, up 9% from $505K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tyndall Capital Partners deployed $48.3K of net new capital in Q4 2023, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tyndall Capital Partners added most to Korsana Biosciences, Inc. Common Stock in Q4 2023, an estimated $48.3K increase.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $551K portfolio in Q4 2023.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q4 2023.
  • Tyndall Capital Partners's portfolio value rose 9% quarter-over-quarter to $551K.

Based on Tyndall Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.